Spring Research Update meeting 2024
Our Spring Research Update Meeting will once again take place at the renowned Royal Society of Medicine, Wimpole Street, London where we invite guests to an inspiring agenda of some of the most up to date news of our funded research.
These research events offer our supporters the chance to meet our funded researchers, who will present and discuss their ongoing projects. They also provide the opportunity to meet with members of the Parkinson’s community and the Cure Parkinson’s team in a relaxed setting. Your presence and support make a difference; if you’ve been before, why not consider bringing along a friend this time.
Join us in person or register to join the online livestream. We look forward to welcoming you!
Our Linked Clinical Trials (iLCT) programme aims to repurpose existing drugs that have shown promise in other diseases and test their effectiveness in people with Parkinson’s. Now in its 12th year, the iLCT initiative is the subject of our spring research update meeting focusing on advancements within the programme and featuring two key-note presentations: Professor Olivier Rascol will provide insights into the results from the phase 2 Lixipark study testing a diabetes drug, while Professor Per Svenningsson will present on the upcoming Montelukast phase 2 clinical trial testing an anti-inflammatory drug.
Agenda:
1.30 pm Registration
2.00 pm Welcome
2.05 pm Professor Per Svenningsson – The Montelukast phase 2 clinical trial – updates and next steps (incl. 10 mins questions)
2.35pm Dr Richard Wyse – The impact of the International Linked Clinical Trials programme
2.45 pm Tea & Coffee break
3.15 pm Professor Olivier Rascol – results from the phase 2 Lixipark study and next steps (incl. 10 mins questions)
3.45 pm Dr Simon Stott – Our central research update
4:10pm Miss Anaya Navangul – The importance of patient engagement
4.20 pm Main Q&A session
5.00 pm Please join us for wine, soft drinks and a light buffet.
Don’t miss out – join our newsletter mailing list and stay informed
How helpful was this content?
/ 5. Vote count:
We are sorry that this content was not useful for you
Let us improve this content
Can you tell us how we can improve this content?